HLA-DP & DQ & DR (class II) Ab.IgG with prozone effect:Prid:Pt:Ser/Plas:Nom:Flow cytometry

Preferred Label : HLA-DP & DQ & DR (class II) Ab.IgG with prozone effect:Prid:Pt:Ser/Plas:Nom:Flow cytometry;

LOINC status : ACTIVE;

LOINC display name : HLA-DP & DQ & DR (class II) Ab.IgG with prozone effect FC Nom;

LOINC long common name : HLA-DP and DQ and DR (class II) IgG with prozone effect [Identifier] in Serum or Plasma by Flow cytometry (FC);

LOINC short name : HLA classII Ab.IgG prozone SerPl FC;

LOINC description : Sometimes high titer antibody can be associated with low levels of detection (low mean fluorescence intensity, MFI, for the Luminex HLA bead assay), a phenomenon often referred to as the prozone effect. This term is intended to report those antibodies that were not detected at significant level with original sample, but became detectable after dilution or assay treatment. Some laboratories refer to these prozone antigens observed, meaning those antigens for which the patient's antibody exhibited prozone effect.;

Details

Origin ID

94433-0;

UMLS CUI

C5381306;

Has component
- Class [LOINC component]
- HLA [LOINC component]
- HLA-DP [LOINC component]
- HLA-DP & DQ & DR (class II) Ab.IgG [LOINC component]
- HLA-DP and DQ and DR (class II) [LOINC component]
- HLA-DP and DQ and DR (class II) IgG with prozone effect [LOINC component]
- HLA-DP+DQ+DR [LOINC component]
- IgG [LOINC component]
Has method
- Flow cytometry (FC) [LOINC method]
Has property
- Presence or Identity [LOINC Property]
Has scale
- Nom [LOINC scale]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- HLA-DP & DQ & DR (class II) Ab.IgG panel:-:Pt:Ser/Plas:-:Flow cytometry [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients